Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity

Read full text
Authors: Claire L. Feerick, Lei Lei, Dawn Swan, Niamh A. Leonard, Kevin Lynch, Oliver Treacy, Thomas Ritter, Janusz Krawczyk, Michael E O'Dwyer, Aideen E. Ryan
Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research

Publication details

Journal / source
Research Repository UCD (University College Dublin)
Publication date
25 February 2026
Language
EN